These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17225283)

  • 1. Complications & side effects. German researchers study breath test for uncovering mitochondrial damage.
    TreatmentUpdate; 2004; 16(7):9-10. PubMed ID: 17225283
    [No Abstract]   [Full Text] [Related]  

  • 2. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity.
    Milazzo L; Piazza M; Sangaletti O; Gatti N; Cappelletti A; Adorni F; Antinori S; Galli M; Moroni M; Riva A
    J Antimicrob Chemother; 2005 Jan; 55(1):84-9. PubMed ID: 15590719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13C-methionine breath test detects drug-related hepatic mitochondrial dysfunction in HIV-infected patients.
    Milazzo L; Menzaghi B; Massetto B; Sangaletti O; Riva A
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):252-3; author reply 253-4. PubMed ID: 16394861
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of antiretroviral treatment on (13) C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study.
    Banasch M; Frank J; Serova K; Knyhala K; Kollar S; Potthoff A; Brockmeyer NH; Goetze O
    HIV Med; 2011 Jan; 12(1):40-5. PubMed ID: 20500232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease- and treatment-related predictors of hepatic mitochondrial dysfunction in chronic HIV infection assessed by non-invasive (13)C-methionine breath test diagnostic.
    Banasch M; Knyhala K; Kollar S; Serova K; Potthoff A; Schlottmann R; Schmidt WE; Brockmeyer NH; Goetze O
    Eur J Med Res; 2008 Sep; 13(9):401-8. PubMed ID: 18948231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of mitochondrial dysfunction in HIV-infected patients under highly active antiretroviral therapy: possibilities beyond the standard procedures.
    Casademont J; Sanjurjo E; Garrabou G; Miró O
    Antivir Ther; 2005; 10 Suppl 2():M65-71. PubMed ID: 16152707
    [No Abstract]   [Full Text] [Related]  

  • 7. 13C-Methionine breath test detects liver mitochondrial impairment in HIV-infected patients with antiretroviral drug-related hyperlactatemia.
    Milazzo L; Riva A; Sangaletti O; Piazza M; Antinori S; Moroni M
    J Acquir Immune Defic Syndr; 2004 Apr; 35(4):429-32. PubMed ID: 15097162
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.
    Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA
    Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects and complications. Swedes compare treatment switching with interruption.
    TreatmentUpdate; 2005 Dec; 17(7):11. PubMed ID: 17225325
    [No Abstract]   [Full Text] [Related]  

  • 10. Uridine supplementation enhances hepatic mitochondrial function in thymidine-analogue treated HIV-infected patients.
    Banasch M; Goetze O; Knyhala K; Potthoff A; Schlottmann R; Kwiatek MA; Bulut K; Schmitz F; Schmidt WE; Brockmeyer NH
    AIDS; 2006 Jul; 20(11):1554-6. PubMed ID: 16847412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver ultrastructural morphology and mitochondrial DNA levels in HIV/hepatitis C virus coinfection: no evidence of mitochondrial damage with highly active antiretroviral therapy.
    Matsukura M; Chu FF; Au M; Lu H; Chen J; Rietkerk S; Barrios R; Farley JD; Montaner JS; Montessori VC; Walker DC; Côté HC
    AIDS; 2008 Jun; 22(10):1226-9. PubMed ID: 18525271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side effects. Using metabolomics for predicting side effects.
    TreatmentUpdate; 2005; 17(5):11-2. PubMed ID: 17219662
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations in acute-phase proteins among HIV-1 infected persons receiving generic HAART in southern India.
    Sundaram M; Srinivas CN; Shankar EM; Balakrishnan P; Solomon S; Kumarasamy N
    J Infect; 2009 Jun; 58(6):465-7. PubMed ID: 19443037
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.
    Rosso R; Nasi M; Di Biagio A; Repetto E; Dentone C; Pinti M; Nemes E; Ferraresi R; Mussini C; Esposito R; Viscoli C; Cossarizza A
    Pediatr Infect Dis J; 2008 Jan; 27(1):17-21. PubMed ID: 18162932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications and side effects. Alberta clinic saves lives but faces new challenges.
    TreatmentUpdate; 2005 Mar; 17(2):1-3. PubMed ID: 17228462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pregnancy on HIV disease progression during the era of highly active antiretroviral therapy.
    Chen PL; Weaver M; Kwok C; Morrison CS
    J Infect Dis; 2008 Apr; 197(7):1075-6; author reply 1076-7. PubMed ID: 18419544
    [No Abstract]   [Full Text] [Related]  

  • 19. Summaries for patients. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and patient outcomes.
    Ann Intern Med; 2007 Apr; 146(8):I28. PubMed ID: 17438312
    [No Abstract]   [Full Text] [Related]  

  • 20. Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study.
    Sarfo FS; Bibby DF; Schwab U; Appiah LT; Clark DA; Collini P; Phillips R; Green I; Dittmar MT; Chadwick DR
    J Antimicrob Chemother; 2009 Sep; 64(3):667-9. PubMed ID: 19549668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.